“From my phone, I could rule the world”: Critical engagement with maternal vaccine information, vaccine confidence builders and post-Zika outbreak rumours in Brazil

Methods in vaccine effectiveness and safety studies: a critical need for vaccine confidence.

As currently designed, vaccineshave as their goal the conversion f a generally healthy but susceptible host, into a host protected gainst a disease (for which the vaccine is being administered) o which the host may be exposed to at a future date. To this nd, a high bar for effectiveness, efficacy, and safety of vaccines s appropriate. Interest in efficacy and safety is not confined to scintists...

Zika Virus Outbreak, Bahia, Brazil

reference spectra for the organism and its close relatives (e.g., B. thailandensis). B. pseudomallei, although different from other Burkholderia spp. in its pathogenicity and epidemiology, is not easily discriminated from B. thailandensis or B. cepacia complex by using phenotypic tests (10). In summary, infection with B. pseudomallei should be considered in patients with pneumonia after travel ...

Addressing the vaccine confidence gap.

Vaccines--often lauded as one of the greatest public health interventions--are losing public confidence. Some vaccine experts have referred to this decline in confidence as a crisis. We discuss some of the characteristics of the changing global environment that are contributing to increased public questioning of vaccines, and outline some of the specific determinants of public trust. Public dec...

Developing a vaccine against Zika

The race to develop a vaccine against Zika began in February 2016, when the unusual clustering of cases of microcephaly and other neurological disorders associated with Zika virus infection led to the declaration of a public health emergency of international concern. When the World Health Organization held its first consultation in March, 14 active vaccine projects had already been announced. T...

Development of a Zika vaccine.